Alkyl Amines Chemicals Ltd Q2 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/soddkaid87nvx0a38m16ooi0.pdf

Key Takeaways


Demand Environment & Volume Outlook

Kirat Patel: "right now in this first half, because of all the ups and downs of the US government, people are a bit nervous and demand is a little constrained. But that could change if all gets settled."

Acetonitrile: The Delayed Catalyst

Kirat Patel: "If we are lucky enough to have full utilization in 2-3 years, we will also expand. But let us see, it is a long way. I mean, there have been a lot of people who have voiced their desire to expand acetonitrile over the last four years. How many have they actually turned up in the market? So, you have seen that."

Product-Level Dynamics

Kirat Patel: "So methylamines is going to be a long item for some time to come yet."

Trade & Raw Material Headwinds

Kirat Patel: "Yes, because what they were probably directing towards the US is now not available to them. So, they are pushing it towards Asia or wherever else they can."

New Product Pipeline & Capex


Guidance & Commitments

CommitmentSpecificsTimeline
Volume growth FY26Subdued vs normal 10-15%Full year FY26
Acetonitrile anti-dumping benefitReal benefit, mainly volume"Fourth quarter onwards" (Q4 FY26)
New product commercializationImport-substitute, dyes/pigments/electronicsQ1 FY27 (mechanical completion Feb-Mar 2026)
Isopropylamine duty protectionMinistry of Commerce recommendationDecember deadline; MoF decision by March
New product investment decisionsA couple of products in pipeline"Next 3 to 6 months" if attractive
Demand recoveryNormal growth resumesConditional on global trade volatility settling

Key Metrics

MetricQ2 FY26
RevenueNo absolute revenue figure stated
Volume growth (H1 FY26 vs H1 FY25)Marginally up, below normal expected range of 10% to 15%
Gross marginsAlmost stable, overall contribution protected
Ethylamine plant utilization60%–70% expected, commissioned ~1.5 years ago with 30,000 tons capacity
Methylamine derivatives share of amine output~30% (including isopropyl and methyl derivatives)
Direct US export exposure~4% of total exports, ~1% of total sales; worst-case direct impact ~1% of topline
Total production capacity (all products)~2 lakh tons (if everything runs perfectly)
Saleable capacity~1.5 lakh tons (after removing ~25% internal consumption)
New product CAPEX (Kurkumbh)₹120 crores, mechanical completion expected Feb–Mar 2026, commercialization Q1 FY27
New product expected asset turnover~1.5x turnover-to-asset ratio
Acetonitrile current sales volume~15,000–16,000 tons
Acetonitrile projected sales volume (2 years)~20,000 tons (assuming current growth rate)
Last acetonitrile plant CAPEX₹150–160 crores
Acetonitrile plant turnaround time~2 years (plus ~1 year for environmental clearances)
DEK capacity~5 tons per day